Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis
Journal of Cystic Fibrosis · 2024
DOI: 10.1016/j.jcf.2023.10.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2024. Verfasst von Rosemary E Maher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Proteome Research, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Li…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Sputum, Proteome, Aminophenols. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manchester Clinical Research Facility, National Institute for Social Care and Health Research.
Abstract (Originalsprache)
BACKGROUND: There have been dramatic clinical improvements in people with cystic fibrosis (PwCF) commenced on the cystic fibrosis conductance regulator (CFTR) modulator elexacaftor/tezacaftor/ivacaftor (ETI). Sputum proteomics is a powerful research technique capable of identifying important airway disease mechanisms. Using this technique, we evaluated how ETI changes the sputum proteome in PwCF. METHODS: Sputum samples from 21 CF subjects pre- and post- ETI, 6 CF controls ineligible for ETI, and 15 healthy controls were analysed by liquid chromatography mass spectrometry. RESULTS: Post-ETI, mean FEV1 % increased by 13.7 % (SD 7.9). Principal component and hierarchical clustering analysis revealed that the post-ETI proteome shifted to an intermediate state that was distinct from pre-ETI and healthy controls, even for those achieving normal lung function. Functional analysis showed incomplete resolution of neutrophilic inflammation. The CF control sputum proteome did not alter. At the protein-level many more proteins increased in abundance than decreased following ETI therapy (80 vs 30; adjusted p value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Proteome Research, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK.
- Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.
- Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK; Division of Infection, Immunity and Respiratory Medicine, University of Mancheste…
- Faculty of Biology, Medicine and Health, University of Manchester, M13 9PL, UK.
- Department of Child Health (University of Liverpool), Institute in the Park, Alder Hey Children's Hospital, Eaton Rd, Liverpool, L12 2AP, UK.
- Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, M13 9PL, UK; Department of Respiratory Medicine, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, M…
Förderung
- Manchester Clinical Research Facility
- National Institute for Social Care and Health Research
Zitieren
APA
Maher, R. E., Barry, P. J., Emmott, E., Jones, A. M., Lin, L., McNamara, P. S., Smith, J. A., & Lord, R. W. (2024). Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.10.019
Vancouver
Maher RE, Barry PJ, Emmott E, Jones AM, Lin L, McNamara PS, et al. Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis. Journal of Cystic Fibrosis. 2024. doi:10.1016/j.jcf.2023.10.019
BibTeX
@article{Maher2024,
author = {Maher, Rosemary E and Barry, Peter J and Emmott, Edward and Jones, Andrew M and Lin, Lijing and McNamara, Paul S and Smith, Jaclyn A and Lord, Robert W},
title = {Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
year = {2024},
doi = {10.1016/j.jcf.2023.10.019}
}
EUVIMED